Answer
No. It is an oral HIF prolyl-hydroxylase inhibitor that stimulates the body's low-oxygen response, including endogenous erythropoietin production and improved iron availability.
Sources for this answer
- Evrenzo (roxadustat) 20, 50, 70, 100 and 150mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.